Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma

American Journal of Gastroenterology

Volumn 104, Issue 11, 2009, Pages 2747-2753

  Okuwaki, Yusuke ^a   Nakazawa, Takahide ^a   Kokubu, Shigehiro ^b   Hidaka, Hisashi ^a   Tanaka, Yoshiaki ^a   Takada, Juichi ^a   Watanabe, Masaaki ^a   Shibuya, Akitaka ^a   Minamino, Tsutomu ^a   Saigenji, Katsunori ^a  

^a KITASATO UNIVERSITY HOSPITAL   (Japan)

^b JUNTENDO UNIVERSITY NERIMA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REPEAT PROCEDURE; SURVIVAL RATE;

AGE FACTORS; AGED; BIOPSY, NEEDLE; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CAUSE OF DEATH; COHORT STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LYMPH NODES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 72049103667     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.414     Document Type: Article

References (34)

1. Okuda K. Hepatocellular carcinoma. J Hepatol 2000 ; 32 : S225-37.
2. Poon RT, Fan ST, Lo CM et al. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 1999 ; 229 : 216-22.
3. Okuwaki Y, Nakazawa T, Shibuya A et al. Intrahepatic distant recurrence after radiofrequency ablation for a single small hepatocellular carcinoma: risk factors and patterns. J Gastroenterol 2008 ; 43 : 71-8.
4. Kim YS, Rhim H, Cho OK et al. Intrahepatic recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of the pattern and risk factors. Eur J Radiol 2006 ; 59 : 432-41.
5. Mazzaferro V, Romito R, Schiavo M et al. Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis. Hepatology 2006 ; 44 : 1543-54.
6. Lin SM, Lin CJ, Hsu CW et al. Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors. Cancer 2004 ; 100 : 376-82.
7. Shiratori Y, Shiina S, Teratani T et al. Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus. Ann Intern Med 2003 ; 138 : 299-306.
8. Kubo S, Nishiguchi S, Hirohashi K et al. Eff ects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial. Ann Intern Med 2001 ; 134 : 963-7.
9. Ikeda K, Arase Y, Saitoh S et al. Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer. Hepatology 2000 ; 32 : 228-32.
10. Tralhao JG, Dagher I, Lino T et al. Treatment of tumour recurrence after resection of hepatocellular carcinoma. Analysis of 97 consecutive patients. Eur J Surg Oncol 2007 ; 33 : 746-51.
11. Chen WT, Chau GY, Lui WY et al. Recurrent hepatocellular carcinoma after hepatic resection: prognostic factors and long-term outcome. Eur J Surg Oncol 2004 ; 30 : 414-20.
12. Shimada M, Takenaka K, Gion T et al. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 1996 ; 111 : 720-6.
13. Nagasue N, Kohno H, Hayashi T et al. Repeat hepatectomy for recurrent hepatocellular carcinoma. Br J Surg 1996 ; 83 : 127-31.
14. Poon RT, Fan ST, Lo CM et al. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation . Ann Surg 2002 ; 235 : 373-82.
15. Choi D, Lim HK, Rhim H et al. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors. Ann Surg Oncol 2007 ; 14 : 2319-29.
16. Taura K, Ikai I, Hatano E et al. Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old. Ann Surg 2006 ; 244 : 265-73.
17. Yang W, Chen MH, Yin SS et al. Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early and late-phase recurrence. AJR Am J Roentgenol 2006 ; 186 : S275-83.
18. Choi D, Lim HK, Kim MJ et al. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy. Radiology 2004 ; 230 : 135-41.
19. Elias D, De Baere T, Smayra T et al. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumor recurrence after hepatectomy. Br J Surg 2002 ; 89 : 752-6.
20. Kudo M, Chung H, Haji S et al. Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score. Hepatology 2004 ; 40 : 1396-405.
21. Nakazawa T, Kokubu S, Shibuya A et al. Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR Am J Roentgenol 2007 ; 188 : 480-8.
22. Kudo M, Okanoue T, Japan Society of Hepatology. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Oncology 2007 ; 72 : S2-15.
23. Matsui O, Kadoya M, Yoshikawa J et al. Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas: local therapeutic eff ect and 5-year survival rate. Cancer Chemother Pharmacol 1994 ; 33 : S84-8.
24. Minagawa M, Makuuchi M, Takayama T et al. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 2003 ; 238 : 703-10.
25. Lencioni R, Cioni D, Bartolozzi C. Percutaneous radiofrequency thermal ablation of liver malignancies: techniques, imaging findings, and clinical results. Abdom Imaging 2001 ; 26 : 345-60.
26. Sato M, Watanabe Y, Tokui K et al. CT-guided treatment of ultrasonically invisible hepatocellular carcinoma. Am J Gastoroenterol 2000 ; 95 : 2102-6.
27. Podnos YD, Henry G, Ortiz JA et al. Laparoscopic ultrasound with radiofrequency ablation in cirrhotic patients with hepatocellular carcinoma: technique and technical considerations. Am Surg 2001 ; 67 : 1181-4.
28. Koda M, Ueki M, Maeda Y et al. Percutaneous sonographically guided radiofrequency ablation with artificial pleural eff usion for hepatocellular carcinoma located under the diaphragm. AJR Am J Roentgenol 2004 ; 183 : 583-8.
29. Hirooka M, Iuchi H, Kumagi T et al. Virtual sonographic radiofrequency ablation of hepatocellular carcinoma visualized on CT but not on conventional sonography. AJR Am J Roentgenol 2006 ; 186 : S255-60.
30. Numata K, Morimoto M, Ogura T et al. Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography. J Ultrasound Med 2008 ; 27 : 395-406.
31. Takayasu K, Wakao F, Moriyama N et al. Postresection recurrence of hepatocellular carcinoma treated by arterial embolization: analysis of prognostic factors. Hepatology 1992 ; 16 : 906-11.
32. Choi GH, Kim DH, Kang CM et al. Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma. Ann Surg Oncol 2008 ; 15 : 618-29.
33. Shimada K, Sakamoto Y, Esaki M et al. Analysis of prognostic factors aff ecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 2007 ; 14 : 2337-47.
34. Shimada M, Takenaka K, Taguchi K et al. Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 1998 ; 227 : 80-5.